HighTower Advisors
KMTS

HighTower Advisors’s Kestra Medical Technologies KMTS Stock Holding History

HighTower Advisors’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$242K Sell
12,159
-127
-1% -$2.99K ﹤0.01% 3337
2025
Q4 		$326K Buy
+12,286
New +$316K ﹤0.01% 2980

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

HighTower Advisors's KMTS Position: Q1 2026 in Review

HighTower Advisors reduced its Kestra Medical Technologies (KMTS) stake by 1% in Q1 2026, selling an estimated $2.99K and leaving 12,159 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #3337.

HighTower Advisors first reported a position in KMTS in Q4 2025 and has held it in 2 quarters since. The position peaked at $326K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • HighTower Advisors held 12,159 shares of Kestra Medical Technologies worth $242K as of Q1 2026.
  • HighTower Advisors sold 127 Kestra Medical Technologies shares in Q1 2026, an estimated $2.99K.
  • Kestra Medical Technologies made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3337 holding.
  • HighTower Advisors first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 2 quarters since.
  • HighTower Advisors's Kestra Medical Technologies position peaked at $326K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.